Anders D. Hove, Director at Anacor Pharmaceuticals, Inc. (ANAC), sold 740,000 shares at $24.87 ($18.4M) on 2014-09-19, disclosed to the SEC on 2014-09-22.
Scheduled sale ($18.4M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $24.87 | 1,500 | $37K | 0.2% |
| 2 | $24.87 | 738,500 | $18.4M | 99.8% |
| Total | $24.87 avg | 740,000 | $18.4M | 100% |
| Filing → |
| ANAC | SELL | 2015-12-17 | $100.1M | — | Filing → |
| ANAC | SELL | 2015-12-15 | $4.7M | — | Filing → |
| ANAC | SELL | 2015-11-12 | $10.4M | — | Filing → |